CompletedPhase 2NCT01276236

Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)

Studying Kaposi sarcoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of California, San Francisco
Principal Investigator
Patrick Unemori, MD
University of California, San Francisco; San Francisco General Hospital (SFGH)
Intervention
Maraviroc(drug)
Enrollment
13 enrolled
Eligibility
18 years · All sexes
Timeline
2011 – 2015

Study locations (1)

Collaborators

Pfizer · ViiV Healthcare

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01276236 on ClinicalTrials.gov

Other trials for Kaposi sarcoma

Additional recruiting or active studies for the same condition.

See all trials for Kaposi sarcoma →

← Back to all trials